The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Takeda Pharmaceutical Co ADR (NYSE: TAK) was $13.06 for the day, down -1.66% from the previous closing price of $13.28. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 1.56 million shares were traded. TAK stock price reached its highest trading level at $13.13 during the session, while it also had its lowest trading level at $13.05.
Ratios:
Our analysis of TAK’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.76. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 24 ’24 when TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares for $8.10 per share. The transaction valued at 29,999,994 led to the insider holds 3,755,583 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 41001349120 and an Enterprise Value of 4939439407104. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.66, and their Forward P/E ratio for the next fiscal year is 28.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1632.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at 1.185 whereas that against EBITDA is 4.088.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $17.11, while it has fallen to a 52-week low of $13.01. The 50-Day Moving Average of the stock is -5.82%, while the 200-Day Moving Average is calculated to be -9.93%.
Shares Statistics:
TAK traded an average of 1.63M shares per day over the past three months and 1304650 shares per day over the past ten days. A total of 3.14B shares are outstanding, with a floating share count of 3.14B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.57% stake in the company. Shares short for TAK as of 1713139200 were 5971933 with a Short Ratio of 3.66, compared to 1710460800 on 5501771.
Dividends & Splits
With its trailing 12-month dividend rate of 184.0, TAK has a forward annual dividend rate of 0.32. Against a Trailing Annual Dividend Yield of 13.855422The stock’s 5-year Average Dividend Yield is 4.73.
